|
RHOT1 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 5.829800E-01 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.158000E-01 |
| Normal-vs-Stage2 |
7.307800E-01 |
| Normal-vs-Stage3 |
6.865600E-01 |
| Normal-vs-Stage4 |
6.708800E-01 |
| Stage1-vs-Stage2 |
4.502200E-01 |
| Stage1-vs-Stage3 |
8.174400E-01 |
| Stage1-vs-Stage4 |
5.089600E-01 |
| Stage2-vs-Stage3 |
5.653400E-01 |
| Stage2-vs-Stage4 |
9.105400E-01 |
| Stage3-vs-Stage4 |
5.518800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
6.856600E-01 |
| Normal-vs-AfricanAmerican |
6.893200E-01 |
| Normal-vs-Asian |
2.911400E-01 |
| Caucasian-vs-AfricanAmerican |
9.242000E-01 |
| Caucasian-vs-Asian |
6.997800E-01 |
| AfricanAmerican-vs-Asian |
6.975200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.581250E-01 |
| Normal-vs-Female |
2.014600E-01 |
| Male-vs-Female |
2.445700E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
3.522800E-01 |
| Normal-vs-Extreme_Weight |
2.196600E-01 |
| Normal-vs-Obese |
8.239000E-01 |
| Normal-vs-Extreme_Obese |
5.601200E-01 |
| Normal_Weight-vs-Extreme_Weight |
9.983600E-01 |
| Normal_Weight-vs-Obese |
3.106000E-01 |
| Normal_Weight-vs-Extreme_Obese |
3.285800E-01 |
| Extreme_Weight-vs-Obese |
2.306000E-01 |
| Extreme_Weight-vs-Extreme_Obese |
2.840400E-01 |
| Obese-vs-Extreme_Obese |
6.084600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
5.835000E-01 |
| Normal-vs-Age(41-60Yrs) |
2.304600E-01 |
| Normal-vs-Age(61-80Yrs) |
5.224300E-02 |
| Normal-vs-Age(81-100Yrs) |
1.954190E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.890600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.786370E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.738810E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.084100E-03 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.033550E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.199200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
9.291600E-01 |
| Normal-VS-Type2 PRCC |
2.792000E-01 |
| Normal-VS-KIRP CIMP |
8.681600E-01 |
| Normal-VS-Unclassified PRCC |
6.759800E-01 |
| Type1 PRCC-VS-Type2 PRCC |
3.460600E-01 |
| Type1 PRCC-VS-KIRP CIMP |
8.768000E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
6.358200E-01 |
| Type2 PRCC-VS-KIRP CIMP |
7.961200E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
2.653600E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
7.103400E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.082600E-01 |
| Normal-vs-N1 |
3.298800E-01 |
| Normal-vs-N2 |
2.719400E-01 |
| N0-vs-N1 |
8.006500E-02 |
| N0-vs-N2 |
8.949200E-01 |
| N1-vs-N2 |
3.868400E-01 |
|
|
